As of 2025-12-16, the Relative Valuation of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is (89.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.28 USD, the upside of Biohaven Pharmaceutical Holding Company Ltd based on Relative Valuation is -892.5%.
The range of the Relative Valuation is (79.40) - (101.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 17.3x | 14.9x |
| Forward P/E multiples | 13.5x - 17.5x | 15.5x |
| Fair Price | (79.40) - (101.75) | (89.40) |
| Upside | -803.9% - -1002.0% | -892.5% |
| Date | P/E |
| 2025-12-15 | -1.97 |
| 2025-12-12 | -1.96 |
| 2025-12-11 | -1.95 |
| 2025-12-10 | -1.80 |
| 2025-12-09 | -1.78 |
| 2025-12-08 | -1.79 |
| 2025-12-05 | -1.62 |
| 2025-12-04 | -1.63 |
| 2025-12-03 | -1.55 |
| 2025-12-02 | -1.50 |
| 2025-12-01 | -1.58 |
| 2025-11-28 | -1.71 |
| 2025-11-26 | -1.61 |
| 2025-11-25 | -1.60 |
| 2025-11-24 | -1.65 |
| 2025-11-21 | -1.65 |
| 2025-11-20 | -1.64 |
| 2025-11-19 | -1.61 |
| 2025-11-18 | -1.61 |
| 2025-11-17 | -1.41 |
| 2025-11-14 | -1.41 |
| 2025-11-13 | -1.37 |
| 2025-11-12 | -1.35 |
| 2025-11-11 | -1.45 |
| 2025-11-10 | -1.32 |
| 2025-11-07 | -1.40 |
| 2025-11-06 | -1.45 |
| 2025-11-05 | -1.42 |
| 2025-11-04 | -2.37 |
| 2025-11-03 | -2.52 |
| 2025-10-31 | -2.92 |
| 2025-10-30 | -2.96 |
| 2025-10-29 | -3.08 |
| 2025-10-28 | -2.92 |
| 2025-10-27 | -2.96 |
| 2025-10-24 | -2.82 |
| 2025-10-23 | -2.77 |
| 2025-10-22 | -2.80 |
| 2025-10-21 | -3.01 |
| 2025-10-20 | -2.98 |
| 2025-10-17 | -2.71 |
| 2025-10-16 | -2.80 |
| 2025-10-15 | -2.95 |
| 2025-10-14 | -2.83 |
| 2025-10-13 | -2.60 |
| 2025-10-10 | -2.69 |
| 2025-10-09 | -2.93 |
| 2025-10-08 | -2.61 |
| 2025-10-07 | -2.55 |
| 2025-10-06 | -2.70 |